関連する実験動画
Updated: Jan 31, 2026

08:34
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
50.6K
p53はメバロナート経路を抑制し,腫瘍抑制を媒介する
Sung-Hwan Moon1, Chun-Hao Huang2, Shauna L Houlihan3
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Cell
|December 25, 2018
まとめ
腫瘍抑制剤p53は メバロナート経路を遮断することで 肝がんを抑制します この経路はコレステロールの生物合成に不可欠であり,SREBP-2の活性化によって調節されます.
科学分野:
- 分子生物学
- 癌 研究
- 生物化学
背景:
- 腫瘍抑制タンパク質p53は 癌の予防に重要な役割を果たします
- p55 が腫瘍形成を抑制する正確なメカニズムは完全に理解されていません.
- メバロナート経路は,コレステロールと非コレステロールイソプレノイドの合成に不可欠です.
研究 の 目的:
- メバロナート経路を抑制するp53の新しい役割を調査する.
- 肝臓におけるp53媒介による腫瘍抑制の基礎となる分子メカニズムを解明する.
- 肝がんにおけるメバロナート経路を標的とした治療戦略を探求する.
主な方法:
- 肝臓がんのマウスモデルを使って
- p53によるメバロナート経路の転写調節を調査した.
- 薬理学的およびRNA干渉 (RNAi) 阻害戦略を使用した.
- 評価されたSREBP-2活性化とABCA1コレステロールトランスポーター遺伝子発現.
主要な成果:
- p53はメバロナート経路を阻害することで腫瘍形成を抑制する.
- p53は,ABCA1遺伝子の転写誘導により,SREBP- 2の活性化を阻害する.
- メバロナート経路の阻害は,p53欠乏したマウスの肝細胞癌の発症を抑制する.
- p53またはABCA1の喪失は,肝臓腫瘍形成を促進し,SREBP- 2の成熟が増加する.
結論:
- メバロナート経路の抑制は,p53媒介の肝臓腫瘍抑制の重要なメカニズムです.
- メバロナート経路を標的とした治療は 肝臓がんの潜在的治療法です
- この研究はp53とコレステロールの 生合成と肝がんの予防の間の新しい関連性を明らかにしています
関連する概念動画
Repressed Memory
519
Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
519
Repressible Operon: trp Operon
1.6K
The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.6K
C4 Pathway and CAM
49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Nonsense-mediated mRNA Decay
11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
Covalently Linked Protein Regulators
9.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.6K
Receptor-mediated Endocytosis
110.9K
Overview
110.9K

